arrow
J

Juana María Cano

ciudad real general university hospital
H指数:16
被引数:894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Socioeconomic disparities in sarcoma diagnosis, expert center access, and advocacy group awareness: a multicenter study in Southern Europe

社会经济差异在肉瘤诊断、专家中心获取和倡导组织意识中的作用:一项南欧多中心研究

2026-09-070
OAAI
Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis

围术期FLOT疗法是否能提高可切除食管腺癌的治愈率?——混合治愈模型分析

2025-11-260
OAAI
Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry

肽受体放射性核素疗法(PRRT)在神经内分泌肿瘤(NET)患者(p)中的再治疗:SEPTRALU国家注册登记研究的西班牙临床经验

2024-09-010
PRE
Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor
2024-09-010
PRE
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain
2024-01-090
OAAI
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry
2023-11-151
PRE
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
2023-03-0624
OAAI
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

Agamenon-seom模型预测接受基于曲妥珠单抗的一线治疗的晚期HER2-positive食管胃腺癌患者的生存

2023-03-041
OAAI
Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
2022-06-010
OAAI
Gastric cancer: Data from the AGAMENON-SEOM study
2021-09-010
OAAI
Differences in coping strategies used by colorectal vs. non-colorectal cancer patients: Data from the Neoetic-SEOM study
2021-07-010
OAAI
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
2021-06-176
OAAI
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry
2021-03-028
OA
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
2020-09-248
OAAI